Published in TB and Outbreaks Week, March 27th, 2001
Prior research has identified neopterin as a marker for "activation of the monocyte/macrophage axis in some clinical situations," said K.H. Mohamed and colleagues. "However, to our knowledge, the relationship of BAL neopterin levels to disease states has not been studied."
The Mohamed team assessed BAL neopterin as a marker in 20 patients with bronchogenic carcinoma, 20 with pulmonary tuberculosis, and 10 healthy controls. The researchers analyzed the concentration of neopterin with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week